Imperial College London
Alternate

ProfessorSimakAli

Faculty of Medicine, Department of Surgery & Cancer

Professor of Molecular Endocrine Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2811simak.ali

 
 
//

Location

 

133ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Rudraraju:2014:10.1007/s10549-014-3098-0,
author = {Rudraraju, B and Droog, M and Abdel-Fatah, TMA and Zwart, W and Giannoudis, A and Malki, MI and Moore, D and Patel, H and Shaw, J and Ellis, IO and Chan, S and Brooke, GN and Nevedomskaya, E and Lo, Nigro C and Carroll, J and Coombes, RC and Bevan, C and Ali, S and Palmieri, C},
doi = {10.1007/s10549-014-3098-0},
journal = {BREAST CANCER RESEARCH AND TREATMENT},
pages = {295--309},
title = {Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer},
url = {http://dx.doi.org/10.1007/s10549-014-3098-0},
volume = {147},
year = {2014}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Rudraraju,B
AU  - Droog,M
AU  - Abdel-Fatah,TMA
AU  - Zwart,W
AU  - Giannoudis,A
AU  - Malki,MI
AU  - Moore,D
AU  - Patel,H
AU  - Shaw,J
AU  - Ellis,IO
AU  - Chan,S
AU  - Brooke,GN
AU  - Nevedomskaya,E
AU  - Lo,Nigro C
AU  - Carroll,J
AU  - Coombes,RC
AU  - Bevan,C
AU  - Ali,S
AU  - Palmieri,C
DO  - 10.1007/s10549-014-3098-0
EP  - 309
PY  - 2014///
SN  - 0167-6806
SP  - 295
TI  - Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer
T2  - BREAST CANCER RESEARCH AND TREATMENT
UR  - http://dx.doi.org/10.1007/s10549-014-3098-0
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341487600006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 147
ER  -
Download